Latest Stem cell treatments Stories

Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis

2013-04-05 08:23:51

ROCKVILLE, Md., April 5, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced today that it received a notice of allowance for patent application 12/404,841. This patent covers methods for treating amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) with expanded spinal cord stem cells, including NSI-566. Neuralstem completed a Phase I safety trial of its NSI-566 stem cells in ALS earlier this year, for which it has also been granted an Orphan Drug Designation. The...

Cell Therapy Could Become As Common As Mainstream Medicine

2013-04-04 09:21:16

April Flowers for redOrbit.com - Your Universe Online A new study from the University of California, San Francisco (UCSF) reveals that treating patients with cells may one day become as common as it is now to treat the sick with drugs from engineered proteins, antibodies, or smaller chemicals. The team outlines their vision of cell-based therapy as a "third pillar of medicine" in an online edition of Science Translational Medicine. "Today, biomedical science sits on the cusp of a...

Dr. Saud A. Sadiq of the Tisch MS Research Center of New York Invited to Speak on Stem Cell Research at Landmark Event Within the Vatican

2013-04-03 23:03:05

Dr. Saud A. Sadiq to Discuss Cellular Therapy for MS at the Second International Adult Stem Cell Conference: Regenerative Medicine – A Fundamental Shift in Science and Culture. New York, NY (PRWEB) April 03, 2013 The Tisch MS Research Center of New York announced today that Dr. Saud A. Sadiq has accepted an invitation to participate in the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture to be held within the Vatican,...

Howard Leonhardt to Present 25 Years of Experience With Stem Cell Transplantation at 28th Annual Interventional Cardiology Conference in Snowmass, Colo., on March 28

2013-03-26 16:28:14

SNOWMASS, Colo., March 26, 2013 /PRNewswire/ -- Howard Leonhardt of Bioheart, Inc., and Leonhardt Ventures will be presenting his team's experience with stem cell transplantation at the 28(th) Annual International Symposium of Interventional Cardiology. The conference, which will explore a comprehensive approach to the percutaneous management of structural heart disease and coronary and peripheral vascular disease, will be held at the Westin Hotel in Snowmass Village, Colo., from...

COFEPRIS leniency opens doors to stem cell therapies

2013-03-25 12:27:06

NEW YORK, March 25, 2013 /PRNewswire/ -- Celltex in Houston moved operations to Mexico early this year along with stem cell companies in India and China who have been inquiring about the Mexican market. According to ReHealth, COFEPRIS, which 2 years ago was closed to stem cell treatment has had a complete change of heart when they approached them again just about a month ago. ReHealth's core business is the development of autologous stem cells for diabetes types 1 and 2, COPD,...

Parent Project Muscular Dystrophy Funds Investigator to Build New Muscle from Skin Cells to Treat Duchenne Muscular Dystrophy

2013-03-21 12:28:17

HACKENSACK, N.J., March 21, 2013 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD) has awarded University of Minnesota researcher Dr. Rita Perlingeiro a grant for $220,000 to develop a therapeutic approach for Duchenne muscular dystrophy (Duchenne) using a new type of "adult-derived" stem cell called "induced pluripotent stem cells" or "iPSCs." iPSCs can be created from non-controversial sources like skin, have the ability to multiply indefinitely, and can be...

Regenerative Heart Medicine Could Get Boost With Nanotechnology

2013-03-21 12:06:19

redOrbit Staff & Wire Reports - Your Universe Online Researchers at the Stanford University School of Medicine have developed a new visualization technique which they believe could eventually help make the repair of damaged hearts through regenerative medicine a reality. In a study published in Wednesday’s edition of the journal Science Translational Medicine, senior author and Stanford radiology professor Sam Gambhir and colleagues describe how they plan to mark the stem cells...

Heart Failure 2013 LA Showcase of SoCal Heart Disease Startups

2013-03-20 08:27:32

Breakthrough First of Kind Technologies Will Be Presented LOS ANGELES, March 20, 2013 /PRNewswire/ -- Heart Failure 2013 LA will be held at the Millennium Biltmore Hotel all day on Saturday April 6(th). Leonhardt Ventures and the Cal-X Stars Life Science Business Accelerator are co-sponsoring @ 5:30pm a side showcase of startups that address heart and cardiovascular disease, most of them based in Southern California or with strong SoCal ties. Companies to be showcased include:...

Cord Blood Registry is Advancing Regenerative Medicine Research at Exciting Pace

2013-03-19 12:27:39

Ground-Breaking Clinical Trials Are Providing Families New Potential Treatment Options SAN BRUNO, Calif., March 19, 2013 /PRNewswire/ -- Cord Blood Registry® (CBR®), the world's largest newborn stem cell bank, is fueling innovation in newborn stem cell research. As CBR prepares to release its 250(th) cord blood unit for medical use this month, the newborn stem cell bank announces that 71% of all its units released for use have been for emerging applications in regenerative...

Stem Cell Orthopedic Applauds New Studies Supporting Plasma Therapy Treatments

2013-03-13 23:00:40

Stem Cell Orthopedic applauds new studies finding Platelet-Rich Plasma (PRP) therapy helpful in treating osteoarthritis. (PRWEB) March 13, 2013 StemCellOrthopedic.com, popular website of the Institute of Regenerative and Molecular Orthopaedics (IRMO), world renowned stem cell therapy experts, applauds the latest studies showing the effectiveness of platelet rich plasma therapy (PRP) on treating osteoarthritis. Multiple studies from around the world have confirmed that PRP therapy...